the use of intravenous procainamide is a reliable and rapid method of identifying patients with the wolff-parkinson-white syndrome who may be at risk for circulatory insufficiency or sudden death in case of atrial fibrillation .
C0033216
procainamide
C0004238
atrial fibrillation